Neil is the founder and past CEO of Lotus Clinical Research, a world-renowned analgesic site and CRO combination. Neil is an expert in analgesic protocol design and implementation, serving as the Chief Medical Officer at Latigo Biotherapeutics. With a deep focus on minimizing variability in clinical trials with subjective endpoints, Neil has been instrumental in pioneering methodologies that enhance the rigor and outcomes of pain management studies.

Neil’s innovative approach includes the development of novel patient education techniques that reduce placebo responses and increase effect sizes, significantly improving the quality of clinical trials in pain management. His work in developing the abdominoplasty model for acute postoperative pain studies has set a new standard in the field, becoming a cornerstone for numerous new drug approvals.

As a respected figure in the scientific community, Neil chairs the Clinical Trials Special Interest Group for the International Association for the Study of Pain (IASP) and has organized and chaired prominent scientific symposia on analgesic trials for both the IASP and the American Pain Society.

Neil earned his Doctor of Medicine from Northeast Ohio Medical University and continues to contribute his extensive expertise to advance the mission of Latigo Biotherapeutics in developing non-opioid pain medicines that target pain at its source.